Related Experiment Video
Updated: Jun 24, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria
1Division of Hematology and Bone Marrow Transplantation, Department of Medicine, University of Utah School of Medicine, 50 North Medical Drive, Salt Lake City, UT 84132, USA. charles.parker@hsc.utah.edu
Hematology/Oncology Clinics of North America
|March 31, 2009
Summary
Paroxysmal nocturnal hemoglobinuria (PNH) arises from immune-mediated bone marrow injury, leading to the natural selection of PIGA-mutant stem cells. This process causes the characteristic hemolysis seen in PNH.
Area of Science:
- Hematology
- Immunology
- Genetics
Background:
- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder.
- The pathophysiology involves complement-mediated intravascular hemolysis.
- Bone marrow hyperplasia is often observed in PNH patients.
Purpose of the Study:
- To explore the etiology of paroxysmal nocturnal hemoglobinuria (PNH).
- To investigate the link between PNH and bone marrow hyperplasia.
- To propose a new model for PNH pathogenesis.
Main Methods:
- Review of existing literature on PNH.
- Analysis of the relationship between immune-mediated bone marrow injury and PNH.
- Discussion of PIGA gene mutations and stem cell selection.
Main Results:
- The study posits that PNH hemolysis is a secondary consequence of PIGA-mutant stem cell selection.
- This selection is proposed as a natural survival response to immune-mediated bone marrow injury.
- Marrow hyperplasia is linked to this underlying injury and compensatory stem cell proliferation.
Conclusions:
- The etiology of PNH is re-framed as an adaptive response to bone marrow injury.
- Complement-mediated hemolysis is an epiphenomenon, not the primary cause.
- Understanding this mechanism may inform PNH management strategies.
Related Concept Videos
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:20Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...